Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBushveld Minerals Regulatory News (BMN)

  • This share is currently suspended. It was suspended at a price of 0.306
  • There is currently no data for BMN

AGM Results

5 Aug 2021 17:00

RNS Number : 7638H
Bushveld Minerals Limited
05 August 2021
 

 

 

5 August 2021

Bushveld Minerals Limited

("Bushveld Minerals", "Bushveld" or the "Company")

Annual General Meeting Results

Bushveld Minerals Limited (AIM: BMN), the AIM quoted, integrated primary vanadium producer and energy storage provider, with ownership of high-grade assets in South Africa, announces that all ordinary resolutions put to shareholders at the Annual General Meeting held earlier today were duly passed. Resolution 9, which was a special resolution requiring 75 per cent of votes cast to be in favour was not passed.

 

No.

ORDINARY RESOLUTIONS

VOTES

IN FAVOUR

AGAINST

WITHHELD

1

To receive and adopt the Annual Financial Statements of the Company and the Directors report and the report of the Auditors for the financial year ended 31 December 2020.

215,800,827

46 917

465 650

2

To approve the Directors Fees as reflected in Remuneration Report and in Note 35 of the Annual Financial Statements.

112,093,663

83,495,345

20,724,386

3

That Messrs RSM UK Audit LLP be reappointed as Auditors to the Company.

210,772,584

5,059,449

481,361

4

That the Directors be authorised to approve the remuneration of the Company's Auditors to the Company

184,609,536

31,208,208

495,650

5

That Anthony Viljoen shall be re-elected as a Director, having retired by rotation and offered himself for re-election.

184,543,956

31,736,892

32,546

6

That Michael Kirkwood shall be re-elected as a Director, having retired by rotation and offered himself for re-election.

182,683,621

33,297,227

332,546

7

The Company be generally and unconditionally authorised for the purposes of Articles 50.3 of the Articles to make on market acquisitions (as defined in Article 50.5 of the Articles) of Ordinary Shares on such terms and in such manner as the Directors determine provided that:

(i) the maximum aggregate number of Ordinary shares which may be purchased is 119,156,154 Ordinary Shares;

(ii) the minimum price (excluding expenses) which may be paid for each Ordinary share is £0.01;

(iii) the maximum price (excluding expenses) which may be paid for any Ordinary Share does not exceed 105 per cent of the average closing price of such shares for the 5 business days of AIM prior to the date of purchase; and

(iv) this authority shall expire at the conclusion of the next Annual General Meeting of the Company unless such authority is renewed prior to that time (except in relation the purchase of Ordinary Shares the contract for which was concluded before the expiry of such authority, in which case such purchase may be concluded wholly or partly after such expiry).

141,968,405

74,313,007

31,982

8

The Directors of the Company be and are hereby authorised to exercise all powers of the Company to issue, grant rights to subscribe for, or to convert any securities into, up 397,187,181 shares (together "Equity Securities") in the capital of the Company being approximately one third of the issued share capital of the Company (excluding treasury shares) in accordance with Article 8.3 of the Articles of Incorporation of the Company such authority to expire, unless previously renewed, revoked or varied by the Company by ordinary resolution, at the end of the next Annual General Meeting of the Company or, if earlier, at the close of business on the date falling 15 months from the date of the passing of this Resolution, but in each case, during this period the Company may make offers, and enter into agreements, which would, or might, require Equity Securities to be issued or granted after the authority given to the Directors of the Company pursuant to this Resolution ends and the Directors of the Company may issue or grant Equity Securities under any such offer or agreement as if the authority given to the Directors of the Company pursuant to this Resolution had not ended. This Resolution is in substitution for all unexercised authorities previously granted to the Directors of the Company to issue or grant Equity Securities; and

135,151,861

79,990,646

1,170,887

 SPECIAL RESOLUTION

9

If Resolution 8 is passed, the Directors of the Company be, and they are hereby authorised to exercise all powers of the Company to issue

or grant Equity Securities in the capital of the Company pursuant to the issue or grant referred to in Resolution 8 as if the pre-emption rights contained in Article 9.9 of the Articles of Incorporation of the Company did not apply to such issue or grant provided that: (A) the maximum aggregate number of Equity Securities that may be issued or granted under this authority is 119,156,154 shares, being approximately 10.0 per cent of the issued share capital of the Company (excluding treasury shares); and (B) the authority hereby conferred, unless previously renewed,

revoked or varied by the Company by special resolution, shall expire at the end of the next Annual General Meeting of the Company or, if earlier, at the close of business on the date falling 15 months from the date of the passing of this Resolution, save that the Company may before such expiry make an offer or agreement which would or might require Equity Securities to be issued or granted after such expiry and the Directors may issue or grant Equity Securities in pursuance of such an offer or agreement as if the authority conferred by the above resolution had not expired. This Resolution is in substitution for all unexercised authorities previously granted to the Directors of the Company to issue or grant Equity Securities in the capital of the Company as if the pre-emption rights contained in Article 9.9 of the Articles of Incorporation of the Company did not apply to such issue or grant.

135,066,664

80,075,843

1,170,887

 

 

 

ENDS

 

Enquiries: info@bushveldminerals.com

Bushveld Minerals

+27 (0) 11 268 6555

Fortune Mojapelo, Chief Executive Officer

Chika Edeh, Head of Investor Relations

SP Angel Corporate Finance LLP

Nominated Adviser & Broker

+44 (0) 20 3470 0470

Richard Morrison / Charlie Bouverat

Grant Baker / Richard Parlons

Peel Hunt Limited

Joint Broker

+44 (0) 20 7418 8900

Ross Allister / Alexander Allen

Tavistock

Financial PR

+44 (0) 20 7920 3150

Gareth Tredway / Tara Vivian-Neal

 

ABOUT BUSHVELD MINERALS LIMITED

Bushveld Minerals is a low-cost, vertically integrated primary vanadium producer. It is one of only three operating primary vanadium producers, owning 2 of the world's 4 operating primary vanadium processing facilities. In 2020, the Company produced more than 3,600 mtV, representing approximately three per cent of the global vanadium market. With a diversified vanadium product portfolio serving the needs of the steel, energy and chemical sectors, the Company participates in the entire vanadium value chain through its two main pillars: Bushveld Vanadium, which mines and processes vanadium ore; and Bushveld Energy, an energy storage solutions provider. Bushveld Vanadium is targeting to materially grow its vanadium production and achieve an annualised steady state production run rate of between 5,000 mtVp.a. and 5,400 mtVp.a by the end of 2022, from projects currently being implemented. Beyond that, pre-feasibility studies are in progress to determine the optimal path to increase production even further to a steady state production run rate of between 6,400 mtVp.a. and 6,800 mtVp.a. in the medium-term and to a steady state production run rate of 8,400 mtVp.a in the long term.

Bushveld Energy is focused on developing and promoting the role of vanadium in the growing global energy storage market through the advancement of vanadium-based energy storage systems, specifically Vanadium Redox Flow Batteries ("VRFBs").

Detailed information on the Company and progress to date can be accessed on the website www.bushveldminerals.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUVVVRAVUWRAR
Date   Source Headline
16th May 20257:00 amRNSCancellation - Bushveld Minerals Limited
15th Apr 20254:28 pmRNSAppointment of Liquidators & Resignation of Nomad
11th Apr 20257:57 amRNSNotice of appointment of liquidators
15th Jan 20256:00 pmRNSBushveld Minerals
16th Dec 20247:15 amRNSBusiness Rescue and Operations Update
4th Dec 20247:00 amRNSResignation of Directors
29th Nov 20247:00 amRNSDefault on Shareholder Loan Repayment by Vanchem
19th Nov 202410:01 amRNSAppointment of Business Rescue Practitioners
18th Nov 20247:30 amRNSSuspension - Bushveld Minerals Limited
18th Nov 20247:00 amRNSTrading Suspension
8th Nov 20249:25 amRNSQ3 and 9M 2024 Operational Update
1st Nov 20243:05 pmRNSVanchem Sale Update
25th Oct 20242:21 pmRNSOperational Update
18th Oct 20249:18 amRNSDisposal of Interests in Lemur Holdings Limited
17th Sep 20247:00 amRNSInterim Results for Six Months ended 30 June 2024
10th Sep 20247:00 amRNSTurnaround Initiatives Underway
2nd Sep 20244:22 pmRNSOrion Matched Funding Received
14th Aug 20246:00 pmRNSSARB Approval for Orion US$10M Matched Funding
12th Aug 20244:13 pmRNSUS$2 million SPR Debt Funding Received
9th Aug 20249:55 amRNSAgreement re Settlement of SPR Subscription Funds
7th Aug 20244:25 pmRNSAnnual General Meeting Results
7th Aug 20247:00 amRNSDirector/PDMR Shareholding
6th Aug 20247:00 amRNSAnnual General Meeting Statement
31st Jul 20247:00 amRNSQ2 and H1 2024 Operational Update
24th Jul 20244:46 pmRNSHolding(s) in Company - Correction
15th Jul 202412:39 pmRNSDirector/PDMR Shareholding
12th Jul 20244:57 pmRNSDirector/PDMR Shareholding
11th Jul 20245:04 pmRNSPosting of Accounts & Notice of General Meeting
28th Jun 20245:30 pmRNSFinal Results for Year Ended 31 December 2023
28th Jun 20243:29 pmRNSFinancing Update: Orion matched funding of US$10m
28th Jun 20241:17 pmRNSHolding(s) in Company
26th Jun 202412:13 pmRNSHolding(s) in Company
24th Jun 20241:50 pmRNSSPR Funding & Orion 2024 Financing Package Update
31st May 20244:07 pmRNSCCSA Approval for sale of 64% interest in Mokopane
31st May 20241:07 pmRNSResult of Meeting
24th May 20245:53 pmRNSShareholder Correspondence and Questions & Answers
13th May 20247:00 amRNSPosting of Circular and Notice of General Meeting
7th May 20247:00 amRNSProposed conditional disposal of Vanchem
23rd Apr 20247:01 amRNSQ1 2024 Operational & Corporate Update
23rd Apr 20247:00 amRNSMineral Resources and Reserves Annual Update
14th Mar 20249:32 amRNSFurther Update on Outstanding Funds
14th Mar 20247:00 amRNSTR-1 Notification of Major Holdings
7th Mar 20243:00 pmRNSTR-1 Notification of Major Holdings
29th Feb 20245:30 pmRNSFurther Update on Outstanding Funds
16th Feb 20247:08 amRNSFurther update on Outstanding Funds
5th Feb 20247:08 amRNSFull year 2023 Operational Update
2nd Feb 20242:30 pmRNSForm 8.3 of the Takeover Code
1st Feb 20247:00 amRNSCompletion of Convertible Loan Note Refinancing
29th Jan 20244:25 pmRNSResignation of Finance Director
19th Jan 20244:32 pmRNSFurther Update on Outstanding Funds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.